HOXA3 and Alzheimer disease: This combined analysis validates a series of concurrent changes in known AD genes such as APP, HOXA3 and ADAM17 and confirms potentially new AD loci such as LRRC8B and MCF2L. The detection of a Braak stage-associated epigenetic change in the APP gene is of particular importance.